Skip to main navigation Skip to search Skip to main content

Tipifarnib as maintenance therapy did not improve disease-free survival in patients with acute myelogenous leukemia at high risk of relapse: Results of the phase III randomized E2902 trial

  • Selina M. Luger
  • , Victoria X. Wang
  • , Jacob M. Rowe
  • , Mark R. Litzow
  • , Elisabeth Paietta
  • , Rhett P. Ketterling
  • , Hillard Lazarus
  • , Witold B. Rybka
  • , Michael D. Craig
  • , Judith Karp
  • , Brenda W. Cooper
  • , Adel Z. Makary
  • , Lynne S. Kaminer
  • , Frederick R. Appelbaum
  • , Richard A. Larson
  • , Martin S. Tallman

Research output: Contribution to journal › Article › peer-review

7   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Tipifarnib as maintenance therapy did not improve disease-free survival in patients with acute myelogenous leukemia at high risk of relapse: Results of the phase III randomized E2902 trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry